• No results found

Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARD-refractory rheumatoid arthritis

N/A
N/A
Protected

Academic year: 2019

Share "Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARD-refractory rheumatoid arthritis"

Copied!
11
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1Patient characteristics, disease activity and patient-reported outcomes at baseline
Table 2Day 1, week 1 and week 12 data from patient daily diaries
Figure 1Change from baseline
Figure 2Change from baseline

References

Related documents

By consolidating these cloudlets together into minimum number of machines whenever possible, when help turn the other underutilized servers into a less power

Pharmacological evidence- The aqueous and alcoholic extract of Hibiscus rosa sinensis flower possessed significant antiulcer activity in pylorus ligation, aspirin

image to avoid non brain tissue information from the image and soft tissues only will left with

Skill development programmes are one of the parts of Life Long Learning programmes organized by the Department of Life Long Learning and Extension, Shivaji

A key difference between the design approach employed for the 110 GHz gyrotron and that employed for the 170 GHz gyrotron is that the former uses a collector

In addition, FA-functionalized liposomes loaded with Ir-1 (FA-L-Ir-1) showed significantly higher cellular uptake in HepG2 cells compared to nontargeted control normal

The quantitative data on the a-ketonic steroid pattern in male urine are found in Table I. Sub- jects are listed by initial and in ascending order of age, with hydrolytic method,

( 15 ) Italy M/66 AML Sputum Positive ITS, calmodulin, and ␤ -tubulin gene sequencing Invasive aspergillosis Voriconazole Died 4 Present study (strain PW2955) Hong Kong M/65